Combined EZH2 and Bcl-2 inhibitors as precision therapy for...

Blood Advances 2020 / 10 Vol. 4; Iss. 20

Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes

Scholze, Hanna, Stephenson, Regan E., Reynolds, Raymond, Shah, Shivem, Puri, Rishi, Butler, Scott D., Trujillo-Alonso, Vicenta, Teater, Matthew R., van Besien, Herman, Gibbs-Curtis, Destini, Ueno, Hid
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2020002580
Date:
October, 2020
File:
PDF, 1.26 MB
2020
Conversion to is in progress
Conversion to is failed